ILK and cancer: Suppression of TGF-β mediated EMT, migration, and invasion of breast and lung cancer cells by LFG-500, a synthetic anti-inflammatory flavonoid with potential anti-cancer properties, operates through down-regulation of ILK expression and subsequent downstream activation of the Hippo signaling pathway [64].